Peter L Lakatos

Peter L Lakatos

UNVERIFIED PROFILE

Are you Peter L Lakatos?   Register this Author

Register author
Peter L Lakatos

Peter L Lakatos

Publications by authors named "Peter L Lakatos"

Are you Peter L Lakatos?   Register this Author

100Publications

3152Reads

32Profile Views

Can we Predict Disease Course with Clinical Factors?

Curr Drug Targets 2018 ;19(7):791-797

1st Department of Medicine, Semmelweis University, Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1389450118666170329095123DOI Listing
October 2019

Risk of Malignant Cancers in Inflammatory Bowel Disease.

J Crohns Colitis 2019 Sep;13(10):1302-1310

Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
https://academic.oup.com/ecco-jcc/advance-article/doi/10.109
Publisher Site
http://dx.doi.org/10.1093/ecco-jcc/jjz058DOI Listing
September 2019

Can We Say No to the 'Nocebo Effect' in Inflammatory Bowel Diseases?

J Crohns Colitis 2019 09;13(9):1095-1096

First Department of Medicine, Semmelweis University, Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ecco-jcc/jjz098DOI Listing
September 2019

Elderly patients with inflammatory bowel disease: Updated review of the therapeutic landscape.

World J Gastroenterol 2019 Aug;25(30):4158-4171

Department of Adult Gastroenterology, McGill University Health Centre, Montreal, QC H3G 1A4, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v25.i30.4158DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700701PMC
August 2019

Clinical Parameters Correlate With Endoscopic Activity of Ulcerative Colitis: A Systematic Review.

Clin Gastroenterol Hepatol 2019 Jun 21;17(7):1265-1275.e8. Epub 2018 Dec 21.

Division of Gastroenterology, McGill University Health Centre, Montreal, Canada; First Department of Medicine, Semmelweis University, Budapest, Hungary. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15423565183139
Publisher Site
http://dx.doi.org/10.1016/j.cgh.2018.12.021DOI Listing
June 2019

Faecal Calprotectin Predicts Endoscopic and Histological Activity in Clinically Quiescent Ulcerative Colitis.

J Crohns Colitis 2019 Jun 10. Epub 2019 Jun 10.

Division of Gastroenterology, Department of Medicine, McGill University, Montreal, QC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ecco-jcc/jjz107DOI Listing
June 2019

Biosimilars for the Management of Inflammatory Bowel Diseases: Economic Considerations.

Curr Med Chem 2019 ;26(2):259-269

First Department of Medicine, Semmelweis University, Koranyi S. 2/A, H-1083 Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/0929867324666170406112304DOI Listing
April 2019

Harmonization of quality of care in an IBD center impacts disease outcomes: Importance of structure, process indicators and rapid access clinic.

Dig Liver Dis 2019 03 3;51(3):340-345. Epub 2018 Dec 3.

Inflammatory Bowel Disease Centre, Division of Gastroenterology, McGill University Health Centre (MUHC), Montreal, Quebec, Canada; 1st Department of Medicine, Semmelweis University, Budapest, Hungary. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2018.11.013DOI Listing
March 2019

High-Dose Infliximab Rescue Therapy for Hospitalized Acute Severe Ulcerative Colitis Does Not Improve Colectomy-Free Survival.

Dig Dis Sci 2019 02 16;64(2):518-523. Epub 2018 Nov 16.

Division of Gastroenterology, Montreal General Hospital, McGill University Health Centre, 1650 Avenue Cedar C7-200, Montreal, QC, H3G 1A4, Canada.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10620-018-5358-z
Publisher Site
http://dx.doi.org/10.1007/s10620-018-5358-zDOI Listing
February 2019

Selection of Quality Indicators in IBD: Integrating Physician and Patient Perspectives.

Inflamm Bowel Dis 2019 01;25(2):403-409

Mount Sinai Hospital, Center for Inflammatory Bowel Disease, Department of Medicine, University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ibd/izy259DOI Listing
January 2019

Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn's disease.

Qual Life Res 2019 Jan 17;28(1):141-152. Epub 2018 Sep 17.

Division of Gastroenterology, Department of Internal Medicine, University of Debrecen, Nagyerdei krt. 98., Debrecen, 4032, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11136-018-2003-4DOI Listing
January 2019

Risk Factors Associated with Clostridium difficile Infection in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

J Crohns Colitis 2019 Jan;13(1):27-38

Division of Gastroenterology, Montreal General Hospital, McGill University Health Center, Montreal, QC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ecco-jcc/jjy143DOI Listing
January 2019

Biosimilars in IBD: Will it Benefit to Patients, Physicians or the Health Care System?

Curr Pharm Des 2019 ;25(1):13-18

First Department of Internal Medicine, Semmelweis University, Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1381612825666190312112900DOI Listing
January 2019

Optimizing Patient Management in Crohn's Disease in a Tertiary Referral Center: the Impact of Fast-Track MRI on Patient Management and Outcomes.

J Gastrointestin Liver Dis 2018 Dec;27(4):391-397

Semmelweis University, First Department of Medicine, Budapest, Hungary;Division of Gastroenterology, McGill University Health Centre, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.15403/jgld.2014.1121.274.ocmDOI Listing
December 2018

Biosimilars in ulcerative colitis: When and for who?

Best Pract Res Clin Gastroenterol 2018 Feb - Apr;32-33:35-42. Epub 2018 May 26.

Semmelweis University, First Department of Internal Medicine, Budapest, Hungary; McGill University, Division of Gastroenterology, Montreal, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bpg.2018.05.003DOI Listing
September 2018

Positioning of old and new biologicals and small molecules in the treatment of inflammatory bowel diseases.

World J Gastroenterol 2018 Aug;24(32):3567-3582

Department of Gastroenterology, McGill University Health Center, Montreal, Québec H4A 3J1, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v24.i32.3567DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113721PMC
August 2018

Progress with infliximab biosimilars for inflammatory bowel disease.

Expert Opin Biol Ther 2018 06 29;18(6):633-640. Epub 2018 Apr 29.

a First Department of Medicine , Semmelweis University , Budapest , Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14712598.2018.1469620DOI Listing
June 2018

Quality of care in inflammatory bowel diseases: What is the best way to better outcomes?

World J Gastroenterol 2018 Jun;24(22):2363-2372

Division of Gastroenterology, McGill University Health Center, Montreal, Québec H4A 3J1, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v24.i22.2363DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000296PMC
June 2018

Comparative Effectiveness of Infliximab Versus Adalimumab in Patients with Biologic-Naïve Crohn's Disease.

Dig Dis Sci 2018 05 14;63(5):1302-1310. Epub 2017 Dec 14.

Division of Gastroenterology, Montreal General Hospital, McGill University Health Center, 1650, Cedar Avenue, C7-200, Montreal, QC, H3G 1A4, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10620-017-4874-6DOI Listing
May 2018

Endoscopic management of Crohn's strictures.

World J Gastroenterol 2018 May;24(17):1859-1867

Division of Gastroenterology and Hepatology, University Hospitals Leuven, Belgium and University of Leuven, Leuven 3000, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v24.i17.1859DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937203PMC
May 2018

The Use of Balloon-assisted Enteroscopy at a Large Volume Centre: A Retrospective Analysis.

J Can Assoc Gastroenterol 2018 Apr 27;1(1):33-39. Epub 2018 Mar 27.

Division of Gastroenterology, McGill University Health Center, Montreal, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jcag/gwy007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488007PMC
April 2018

Cost-utility of biological treatment sequences for luminal Crohn's disease in Europe.

Expert Rev Pharmacoecon Outcomes Res 2017 Dec 28;17(6):597-606. Epub 2017 Apr 28.

a Department of Health Economics , Corvinus University of Budapest , Budapest , Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737167.2017.1322509DOI Listing
December 2017

Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort.

Inflamm Bowel Dis 2017 11;23(11):1908-1915

1First Department of Medicine, Semmelweis University, Budapest, Hungary; 2First Department of Internal Medicine, University of Szeged, Szeged, Hungary; 3Department of Clinical Studies, Faculty of Health Sciences, Semmelweis University, Budapest, Hungary; 4Department of Gastroenterology, Military Hospital-State Health Centre, Budapest, Hungary; 5First Department of Medicine, Peterfy Hospital, Budapest, Hungary; 6Second Department of Medicine, Zala County Hospital, Zalaegerszeg, Hungary; 7Second Department of Medicine, B-A-Z County and University Teaching Hospital, Miskolc, Hungary; 8Department of Internal Medicine, Csolnoky Ferenc Regional Hospital, Veszprem, Hungary; 9Second Department of Internal Medicine, Semmelweis University, Budapest, Hungary; 10Department of Gastroenterology, University of Debrecen, Debrecen, Hungary; 11Department of Medicine and Gastroenterology, Markusovszky Hospital, Szombathely, Hungary; 12Department of Gastroenterology, Tolna County Teaching Hospital, Szekszard, Hungary; 13Department of Gastroenterology, Janos Hospital, Budapest, Hungary; 14First Department of Medicine, University of Pecs, Pecs, Hungary; 15Department of Laboratory Medicine, Semmelweis University, Budapest, Hungary; and 16Division of Gastroenterology, McGill University, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0000000000001237DOI Listing
November 2017

Access to biologicals in Crohn's disease in ten European countries.

World J Gastroenterol 2017 Sep;23(34):6294-6305

Department of Health Economics, Corvinus University of Budapest, H-1093 Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v23.i34.6294DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603496PMC
September 2017

Systematic review and meta-analysis of colon cleansing preparations in patients with inflammatory bowel disease.

World J Gastroenterol 2017 Aug;23(32):5994-6002

Division of Gastroenterology, Department of Medicine, McGill University Health Center, Montreal, QC H3G1A4, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v23.i32.5994DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583585PMC
August 2017

The NOD2-Smoking Interaction in Crohn's Disease is likely Specific to the 1007fs Mutation and may be Explained by Age at Diagnosis: A Meta-Analysis and Case-Only Study.

EBioMedicine 2017 Jul 16;21:188-196. Epub 2017 Jun 16.

Department of Medicine, University of Calgary, Calgary, Alberta, Canada; Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada; O'Brien Institute for Public Health, University of Calgary, Calgary, Alberta, Canada; Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada; (i)Alberta Inflammatory Bowel Disease Consortium, University of Calgary, Calgary, Alberta, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2017.06.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514403PMC
July 2017

The incidence of glomerulonephritis in a population-based inception cohort of patients with inflammatory bowel disease.

Dig Liver Dis 2017 Jun 8;49(6):718-719. Epub 2017 Apr 8.

Semmelweis University, First Department of Medicine, Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2017.03.029DOI Listing
June 2017

The natural history of Crohn's disease in children: a review of population-based studies.

Eur J Gastroenterol Hepatol 2017 Feb;29(2):125-134

aIBD Clinical and Research Centre, ISCARE bInstitute of Pharmacology, First Faculty of Medicine, Charles University, Prague, Czech Republic cEPICOM, European Crohn & Colitis Organisation dGastroenterology Unit, EPIMAD Registry, Amiens University Hospital, University of Picardie Jules Verne, Amiens eGastroenterology Unit, Inserm U954, Nancy University and Hospital, Nancy fPublic Health, Epidemiology and Economic Health, EPIMAD Registry, Maison Régionale de la Recherche Clinique, Centre Hospitalier Universitaire Régional gLille Inflammation Research International Center LIRIC - UMR 995 Inserm/Université Lille 2/CHRU de Lille; Equipe IBD and Environmental factors: Epidemiology and Functional Analyses, Lille University, Lille, France hDepartment of Emergency, Unit of Gastroenterology, AOU Careggi, Florence, Italy iFirst Department of Medicine, Semmelweis University, Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MEG.0000000000000761DOI Listing
February 2017

IBD in 2016: Biologicals and biosimilars in IBD - the road to personalized treatment.

Nat Rev Gastroenterol Hepatol 2017 Feb 11;14(2):74-76. Epub 2017 Jan 11.

First Department of Medicine, Semmelweis University, Koranyi Sandor str. 2/a, 1083 Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrgastro.2016.206DOI Listing
February 2017

Epidemiology of inflammatory bowel diseases from west to east.

J Dig Dis 2017 Feb;18(2):92-98

First Department of Medicine, Semmelweis University, Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1751-2980.12449DOI Listing
February 2017

Real-Life Efficacy, Immunogenicity and Safety of Biosimilar Infliximab.

Dig Dis 2017 1;35(1-2):101-106. Epub 2017 Feb 1.

First Department of Medicine, Semmelweis University, Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000449089DOI Listing
February 2017

ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease-An Update.

J Crohns Colitis 2017 Jan 7;11(1):26-34. Epub 2016 Dec 7.

ECCO Governing Board; Gastroenterology and Inserm U954, University Hospital of Nancy, Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ecco-jcc/jjw198DOI Listing
January 2017

A budget impact model for biosimilar infliximab in Crohn's disease in Bulgaria, the Czech Republic, Hungary, Poland, Romania, and Slovakia.

Expert Rev Pharmacoecon Outcomes Res 2016 10;16(1):119-25. Epub 2015 Jul 10.

a 1 Department of Health Economics, Corvinus University of Budapest, Fővám tér 8, H-1093 Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737167.2015.1067142DOI Listing
October 2016

Biosimilar Monoclonal Antibodies for Inflammatory Bowel Disease: Current Comfort and Future Prospects.

Drugs 2016 Oct;76(15):1413-1420

First Department of Medicine, Semmelweis University, Koranyi Sandor str. 2/a, 1083, Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40265-016-0638-4DOI Listing
October 2016

Perceived Risks Contra Benefits of Using Biosimilar Drugs in Ulcerative Colitis: Discrete Choice Experiment among Gastroenterologists.

Value Health Reg Issues 2016 09 5;10:85-90. Epub 2016 Oct 5.

First Department of Medicine, Semmelweis University, Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vhri.2016.07.004DOI Listing
September 2016

Risk factors for complications in patients with ulcerative colitis.

United European Gastroenterol J 2016 Apr 19;4(2):281-7. Epub 2016 Jan 19.

Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2050640615627533DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804379PMC
April 2016

Adenomatous polyps in ulcerative colitis and colonic Crohn's disease: less frequent, but does this change surveillance strategy?

Endoscopy 2016 Mar 23;48(3):210-2. Epub 2016 Feb 23.

1st Department of Medicine, Semmelweis University, Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0042-100203DOI Listing
March 2016

Treatment preferences of originator versus biosimilar drugs in Crohn's disease; discrete choice experiment among gastroenterologists.

Scand J Gastroenterol 2016 Jan 10;51(1):22-7. Epub 2015 Jun 10.

c 3 1st Department of Medicine, Semmelweis University, Korányi Sándor utca 2a , H-1083 Budapest, Hungary, Europe.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/00365521.2015.1054422DOI Listing
January 2016

Baseline Characteristics and Disease Phenotype in Inflammatory Bowel Disease.

J Pediatr Gastroenterol Nutr 2016 Jan;62(1):50-5

*First Department of Pediatrics †First Department of Medicine, Semmelweis University ‡Heim-Madarász Hospital, Budapest §Department of Pediatrics, Szent-Györgyi Albert University, Szeged ||Department of Pediatrics, Clinical Center, University of Debrecen, Debrecen ¶Department of Pediatrics, University of Pécs, Pécs #Balassa Hospital, Szekszard **Institute of Internal Medicine, Department of Gastroenterology, University of Debrecen, Clinical Center, Debrecen ††BAZ County Hospital, Miskolc ‡‡Csolnoky Hospital, Veszprém §§Josa Hospital, Nyíregyháza ||||Petz County Hospital, Győr, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPG.0000000000000885DOI Listing
January 2016

Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort.

Inflamm Bowel Dis 2015 Aug;21(8):1794-800

1Division of Gastroenterology and Hepatology, Department of Internal Medicine, University Hospital Zurich, Zurich, Switzerland; 2Department of Medicine, Division of Gastroenterology and Hepatology, Triemlispital Zurich, Zurich, Switzerland; 3Private Practice for Dermatology, Zurich, Switzerland; 4Department of Dermatology, University Hospital Zurich, Switzerland; 5Division of Genetics and Molecular Medicine, King's College, London, United Kingdom; 6Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland; 7Institute of Social and Preventive Medicine (IUMSP), University of Lausanne, Lausanne, Switzerland; 8Department of Medicine, Division of Gastroenterology and Hepatology, University Hospital Basel, Basel, Switzerland; 9Crohn's and Colitis Center, Clinique de La Source, Lausanne, Switzerland; 101st Department of Medicine, Semmelweis University, Budapest, Hungary; 11Department of Medicine, Gastroenterology, Spital Netz Bern Tiefenau, Bern, Switzerland; 12Inserm U954 and Department of Hepato-Gastroenterology, University Hospital of Nancy-Brabois, Université Henri Poincaré 1, Vandoeuvre-lès-Nancy, France; and 13Department of Medicine, Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/ibdjournal/2015/08000/Chronolog
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/MIB.0000000000000429DOI Listing
August 2015

Extraintestinal Manifestations of Inflammatory Bowel Disease.

Inflamm Bowel Dis 2015 Aug;21(8):1982-92

*Department of Medicine, Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland; †Department of Medicine, Division of Gastroenterology and Hepatology, Triemlispital Zurich, Zurich, Switzerland; ‡Department of Medicine, Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland; §1st Department of Medicine, Semmelweis University, Budapest, Hungary; and ‖Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0000000000000392DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511685PMC
August 2015

Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe.

World J Gastroenterol 2015 Jun;21(21):6728-35

Zsuzsanna Kurti, Barbara D Lovasz, Michael D Mandel, Zoltan Csima, Petra A Golovics, Bence D Csako, Anna Mohas, Lorant Gönczi, Krisztina B Gecse, Lajos S Kiss, Miklos Szathmari, Peter L Lakatos, 1 Department of Medicine, Semmelweis University, H-1083 Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v21.i21.6728DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458783PMC
June 2015

Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.

World J Gastroenterol 2015 Jun;21(22):6952-64

Nora Sipeki, Laszlo Davida, Eszter Palyu, Istvan Altorjay, Maria Papp, Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v21.i22.6952DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462737PMC
June 2015

Prevalence and predictors of hospitalization in Crohn's disease in a prospective population-based inception cohort from 2000-2012.

World J Gastroenterol 2015 Jun;21(23):7272-80

Petra A Golovics, Michael D Mandel, Barbara D Lovasz, Zsuzsanna Vegh, Zsuzsanna Kurti, Lajos S Kiss, Peter L Lakatos, First Department of Medicine, Semmelweis University, H-1083 Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v21.i23.7272DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476890PMC
June 2015

Have biologics changed the natural history of Crohn's disease?

Dig Dis 2014 23;32(4):351-9. Epub 2014 Jun 23.

First Department of Medicine, Semmelweis University, Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000358135DOI Listing
February 2015

Biological therapy in inflammatory bowel diseases: access in Central and Eastern Europe.

World J Gastroenterol 2015 Feb;21(6):1728-37

Fanni Rencz, Márta Péntek, László Gulácsi, Department of Health Economics, Corvinus University of Budapest, H-1093 Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v21.i6.1728DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323448PMC
February 2015

Costs and resource utilization for diagnosis and treatment during the initial year in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom Study.

Inflamm Bowel Dis 2015 Jan;21(1):121-31

1Digestive Disease Centre, Medical Section, Herlev University Hospital, Copenhagen, Denmark; 2Department of Public Health, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel; 3Division of Gastroenterology and Hepatology, University Hospital Center Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia; 4Private Practice, Nicosia, Cyprus; 5IBD Center ISCARE, Charles University, Prague, Czech Republic; 6Department of Gastroenterology, Hospital České Budějovice, České Budějovice, Czech Republic; 7Department of Medicine, Amager Hospital, Amager, Denmark; 8Department of Medicine, Herning Central Hospital, Herning, Denmark; 9Medical Department, Viborg Regional Hospital, Viborg, Denmark; 10Organ Center, Hospital of Southern Jutland, Aabenraa, Denmark; 11Institute of Regional Health Research, University of Southern Denmark, Odense, Denmark; 12Department of Medicine V (Hepatology and Gastroenterology), Aarhus University Hospital, Arhus, Denmark; 13Department of Medical Gastroenterology, Odense University Hospital, Odense, Denmark; 14Division of Endocrinology and Gastroenterology, Tartu University Hospital, Tartu, Estonia; 15Medical Department, The National Hospital of the Faroe Islands, Torshavn, Faroe Islands; 16Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, Tampere, Finland; 17First Division of Internal Medicine and Hepato-Gastroenterology Unit, University Hospital, Ioannina, Greece; 18Medical Department, Dronning Ingrids Hospital, Nuuk, Greenland; 19First Department of Medicine, Semmelweis University, Budapest, Hungary; 20Department of Gastroenterology, Adelaide and Meath Hospital, TCD, Dublin, Ireland; 21Department of Gastroenterology and Hepatology, Soroka Medical Center, Ben Gurion University of the Negev, Beer Sheva, Israel; 22U.O. di Gastroenterologia e Endoscopia Digestiva, Az.Ospedaliera Ospedale Maggiore di Crema, Crema, Italy; 23EpiCom Northern Italy centre based in Crema a

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0000000000000250DOI Listing
January 2015

Adalimumab monotherapy versus combination therapy with immunomodulators in patients with Crohn's disease: a systematic review and meta-analysis.

J Crohns Colitis 2014 Dec 25;8(12):1632-41. Epub 2014 Jul 25.

Division of Gastroenterology, McGill University Health Center, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.crohns.2014.07.003DOI Listing
December 2014

Enteroscopy in small-bowel Crohn's disease (CD): hypes and hopes.

Endosc Int Open 2014 Dec;2(4):E199-200

1st Department of Medicine, Semmelweis University, Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0034-1390881DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424872PMC
December 2014

Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature.

J Crohns Colitis 2014 Nov 18;8(11):1351-61. Epub 2014 Jun 18.

1st Department of Medicine, Semmelweis University, Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.crohns.2014.05.006DOI Listing
November 2014

Ulcerative proctitis: an update on the pharmacotherapy and management.

Expert Opin Pharmacother 2014 Aug 16;15(11):1565-73. Epub 2014 May 16.

Semmelweis University, 1st Department of Medicine , Korányi Sándor utca 2a, H1083 Budapest , Hungary +36 20 9117727 ; +36 1 3130250 ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2014.920322DOI Listing
August 2014

Serological studies in inflammatory bowel disease: how important are they?

Curr Opin Gastroenterol 2014 Jul;30(4):359-64

aDepartment of Gastroenterology, Institute of Medicine, University of Debrecen, Debrecen b1st Department of Medicine, Semmelweis University, Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOG.0000000000000076DOI Listing
July 2014

Azathioprine in early Crohn's disease: time to revisit patient selection and end points for clinical trials and/or azathioprine efficacy?

Gastroenterology 2014 Mar 24;146(3):867-8. Epub 2014 Jan 24.

IBD Unit, Inserm U954, Nancy University Hospital, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2013.11.053DOI Listing
March 2014

Immune dysfunction in cirrhosis.

World J Gastroenterol 2014 Mar;20(10):2564-77

Nora Sipeki, Maria Papp, Institute of Medicine, Department of Gastroenterology, University of Debrecen, H-4032 Debrecen, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v20.i10.2564DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3949265PMC
March 2014

Inflammatory bowel disease course in Crohn's disease: is the natural history changing?

World J Gastroenterol 2014 Mar;20(12):3198-207

Petra A Golovics, Michael D Mandel, Barbara D Lovasz, Peter L Lakatos, First Department of Medicine, Semmelweis University, H-1083 Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v20.i12.3198DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964392PMC
March 2014

Methotrexate: should we start using it in clinical practice?

Curr Drug Targets 2013 Nov;14(12):1480-9

1st Department of Medicine, Semmelweis University, H-1083 Budapest, Korányi S. 2A, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/13894501113149990604DOI Listing
November 2013

Mucosal healing and deep remission: what does it mean?

World J Gastroenterol 2013 Nov;19(43):7552-60

Gerhard Rogler, Stephan Vavricka, Division of Gastroenterology and Hepatology, Department of Internal Medicine, University Hospital Zürich, 8091 Zürich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v19.i43.7552DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3837253PMC
November 2013

Reply: To PMID 23399739.

Inflamm Bowel Dis 2013 Sep;19(10):E84

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0b013e31829f03daDOI Listing
September 2013

Clinical aspects of mucosal healing in inflammatory bowel diseases: what is it and what is the real value for the everyday practice?

Expert Rev Clin Immunol 2013 Sep;9(9):871-82

2nd Department of Medicine, Semmelweis University, H-1083 Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/1744666X.2013.824675DOI Listing
September 2013

A review of mortality and surgery in ulcerative colitis: milestones of the seriousness of the disease.

Inflamm Bowel Dis 2013 Aug;19(9):2001-10

Section of Gastroenterology, IBD Clinical and Research Centre, University of Manitoba, Winnipeg, Manitoba, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0b013e318281f3bbDOI Listing
August 2013